Prof. Gang Li, MBBS, D. Phil. (Oxon), FIORS, FORS
Professor and Principle Investigator, Institute of Biomedicine and Biotechnology
Director, Center for Locomotor System Regenerative Medicine and Technology
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences
Postal Address: Room 1012, Block B, Shenzhen Institute of Advanced Sciences,
1068 Xueyuan Road, University Town of Shenzhen, 518055, Shenzhen, PR China.
E-mail: gang.li6@siat.ac.cn
Research Areas
Stem cells biology and applications in musculoskeletal tissue engineering; innovative applications distraction osteogenesis technologies.
Education
Prof Gang Li received his Bachelor of Medicine from the Fourth Military Medical University in Xi'an, China in 1991; DPhil Oxford University, UK in 1997.
From 1991 to 1994, he served as a resident surgeon in the emergency surgery and orthopedics department of Beijing PLA General Hospital.
1998-1999 Postdoctoral Fellow in Orthopedics, Oxford University, UK.
Experience
From 1999 to 2004, he served as a lecturer and senior lecturer in the Department of Orthopedics at Queen's University Belfast School of Medicine in the UK.
From 2004 to 2009, he served as a professor at the Cancer and Cell Biology Research Centre at Queen's University Belfast in the UK.
From 2009.02 to 2024.07, full professor in the Department of Orthopedics and Traumatology at the Faculty of Medicine, The Chinese University of Hong Kong.
In August 2024, he joined the Chinese Academy of Sciences Shenzhen Advanced Technology Research Institute as a Professor and Principle Investigator, Director of Center for Locomotor System Regenerative Medicine and Technology, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; and he is a licensed surgeon in PR China.
Publications
Papers
(2) Metabolite-dependent m6 A methylation driven by mechanotransduction-metabolism-epitranscriptomics axis promotes bone development and regeneration, Cell Reports, 2025, corresponding author
(3) Elevated type I IFN signaling directly affects CD8+��T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients., Journal of Autoimmunity, 2024, corresponding author
(4) Augmenting osteoporotic bone regeneration through a hydrogel-based rejuvenating microenvironment, Bioactive Materials, 2024, corresponding author
(5) Biomimetic Nanofibrillar Hydrogel with Cell-Adaptable Network for Enhancing Cellular Mechano-transduction,Metabolic Energetics, and Bone Regeneration., Journal of American Chemical Society, 2023, corresponding author
(6) Complex coacervate-derived hydrogel with asymmetric and reversible wet bioadhesion for preventing UV light-induced morbidities, Bioactive Materials, 2023, corresponding author
(7) Low-Dose Staphylococcal Enterotoxin C2 Mutant Maintains Bone Homeostasis via Regulating Crosstalk between Bone Formation and Host T-Cell Effector Immunity., Advanced Science, 2023, corresponding author
(8) O-alg-THAM/gel hydrogels functionalized with engineered microspheres based on mesenchymal stem cell secretion recruit endogenous stem cells for cartilage repair., Bioactive Materials, 2023, corresponding author
Honors & Distinctions
First prize of the National Ministry of Education’s Higher Education Institutions Natural Science Research Outstanding Achievement Award (2014);
The First prize of the Huaxia Medical Science and Technology Progress Award (2017);
The first prize of the China Ministry of Science and Technology’s Science and Technology Progress Award (2021);
Outstanding Scientist Award of International Society for Tissue Engineering and Regenerative Medicine (Asia-Pacific Chapter, 2024);
Clinical Translation Silver Award of Journal of Orthopedic Translation (2024).